STRO ▲ +0.2% - Sutro Biopharma, Inc.
$STRO - Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
21-OCT-2026 08:00 AM ET
Share this post
More filings for $STRO
STRO ▼ -0.1% - Sutro Biopharma, Inc.Oct 12, 2026$STRO SEC Filing Update (30-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 30, 2026
View full $STRO filing history →💬 Comments
Loading comments…
Leave a comment